E. Price

发表

Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome

R. Moots, L. Sharples, P. Emery, 2017, Arthritis & rheumatology.

Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials

Claire M. Riddell, R. Moots, D. Symmons, 2019, The Lancet Rheumatology.

Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines

R. Moots, D. Isenberg, B. Griffiths, 2016, RMD Open.

An objective method of diagnosing hydroxychloroquine maculopathy

A. Lotery, E. Price, Hani Hasan, 2020, Eye.

Basic science232. Certolizumab pegol prevents pro-inflammatory alterations in endothelial cell function

H. L. Wright, R. Moots, T. Spector, 2012 .

How to treat Sjögren's syndrome.

A. Baer, E. Price, 2019, Rheumatology.

Dry eyes and mouth syndrome--a subgroup of patients presenting with sicca symptoms.

P. Venables, E. Price, 2002, Rheumatology.

Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic.

B. Griffiths, C. Holroyd, L. Kay, 2020, Clinical medicine.

Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic.

B. Griffiths, C. Holroyd, L. Kay, 2020, Clinical medicine.

Odd combinations-coexistence of anti-glomerular basement membrane disease and Sjögren's syndrome.

I. Roberts, E. Price, Azeem Ahmed, 2019, Rheumatology.

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

K. C. Morris, Mohammed Salah Ibrahim, K. Y. Wong, 2022, medRxiv.

The etiopathogenesis of Sjögren's syndrome.

P. Venables, E. Price, Elizabeth J. Price, 1995, Seminars in arthritis and rheumatism.

Cardiovascular risk factors in women with primary Sjögren ' s syndrome

R. Moots, D. Isenberg, B. Griffiths, 2015 .

Subjective and Objective Measures of Dryness Symptoms in Primary Sjögren's Syndrome: Capturing the Discrepancy

R. Moots, D. Symmons, D. Isenberg, 2017, Arthritis care & research.

Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.

R. Moots, D. Isenberg, B. Griffiths, 2017, Rheumatology.

Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.

R. Moots, D. Isenberg, B. Griffiths, 2015, Rheumatology.

T cell clones from a Sjögren's syndrome salivary gland biopsy produce high levels of IL‐10

M. Feldmann, R. Maini, S. Cohen, 1996, Clinical and experimental immunology.

Barriers to translational research in Sjögren's syndrome with childhood onset: challenges of recognising and diagnosing an orphan rheumatic disease.

Coziana Ciurtin, E. Price, E. Jury, 2021, The Lancet. Rheumatology.

The management of Sjögren's syndrome: British Society for Rheumatology guideline scope.

Coziana Ciurtin, A. Tappuni, S. Rauz, 2020, Rheumatology.

The TRACTISS Protocol: a randomised double blind placebo controlled clinical TRial of Anti-B-Cell Therapy In patients with primary Sjögren’s Syndrome

P. Emery, S. Rauz, C. Pease, 2014, BMC Musculoskeletal Disorders.

Safety and efficacy of filgotinib, lanraplenib and tirabrutinib in Sjögren’s syndrome: a randomized, phase 2, double-blind, placebo-controlled study

A. Kivitz, Afsaneh Mozaffarian, M. Bombardieri, 2022, Rheumatology.

Effect of rituximab on a salivary gland ultrasound score in primary Sjögren’s syndrome: results of the TRACTISS randomised double-blind multicentre substudy

R. Moots, L. Sharples, P. Emery, 2017, Annals of the rheumatic diseases.

A double blind placebo controlled trial of azathioprine in the treatment of primary Sjögren's syndrome.

P. Venables, E. Price, S. Rigby, 1998, The Journal of rheumatology.

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Steve B Jones, K. Y. Wong, Chamil H. Hettiarachchi, 2021, Lancet.

The British Society for Rheumatology guideline for the management of adults with primary Sjögren’s Syndrome

W. Ng, A. Tappuni, S. Rauz, 2017, Rheumatology.

Treatment strategies for Sjögren’s syndrome with childhood onset: a systematic review of the literature

Coziana Ciurtin, S. Lieberman, A. Ramanan, 2021, Rheumatology.

Systematic review and meta analysis Treatment strategies for Sjo¨gren’s syndrome with childhood onset: a systematic review of the literature treatment, systematic

S. Lieberman, A. Ramanan, E. Price, 2021 .

The British Society for Rheumatology guideline for the management of adults with primary Sjögren's Syndrome.

W. Ng, A. Tappuni, S. Rauz, 2017, Rheumatology.

A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren’s Syndrome

Anil Wipat, Ian Giles, Jennifer Hallinan, 2015, PloS one.

EP01 Post COVID-19 reactive arthritis

E. Price, Azeem Ahmed, D. Collins, 2020, Rheumatology Advances in Practice.

Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjögren's syndrome

R. Moots, D. Isenberg, B. Griffiths, 2011, Annals of the rheumatic diseases.

Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren’s syndrome

R. Moots, D. Isenberg, B. Griffiths, 2019, RMD Open.

Physical activity but not sedentary activity is reduced in primary Sjögren’s syndrome

R. Moots, D. Symmons, K. Chakravarty, 2016, Rheumatology International.

Cardiovascular Risk Factors in Women With Primary Sjögren's Syndrome: United Kingdom Primary Sjögren's Syndrome Registry Results

R. Moots, D. Isenberg, B. Griffiths, 2014, Arthritis care & research.

Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome.

D A Isenberg, D. Isenberg, A. Jones, 2007, Rheumatology.

Estimating Indirect Costs in Primary Sjögren’s Syndrome

D. Isenberg, S. Rauz, S. Bowman, 2010, The Journal of Rheumatology.

Fatigue in primary Sjögren’s syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study

Claire M. Riddell, R. Moots, D. Symmons, 2019, Rheumatology International.

R. Moots, D. Isenberg, B. Griffiths, 2013, Annals of the rheumatic diseases.

The Sjögren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjögren's syndrome.

R. Barry, D. Isenberg, A. Jones, 2008, Rheumatology.

Interferon-gamma and epithelial cell activation in Sjögren's syndrome.

P. Venables, R. Maini, E. Price, 1995, British journal of rheumatology.

Soluble molecule profiling and network analysis of primary Sjögren's Syndrome patient serum

D. Isenberg, P. Emery, J. Tarn, 2013, BMC Musculoskeletal Disorders.

Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry.

R. Moots, D. Isenberg, B. Griffiths, 2018, Swiss medical weekly.

Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?

R. Moots, D. Isenberg, B. Griffiths, 2015, Rheumatology.

The British Society for Rheumatology guideline for the management of adults with primary Sjögren’s Syndrome

W. Ng, A. Tappuni, S. Rauz, 2017, Rheumatology.

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

K. C. Morris, Michele R. Shaw, Mohammed Salah Ibrahim, 2023, The Lancet.